1 |
Oat
| 1件: Oats Oats | - | - | - | 1件: 97 97 |
2 |
Obatoclax
| 1件: Obatoclax Obatoclax | - | - | - | 1件: 60 60 |
3 |
Obeticholic acid
| 4件: 6-ECDCA 6-ECDCA; 6-ethylchenodeoxycholic acid; OBETICHOLIC ACID; Ocaliva | 1件: D09360
D09360
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 3件: 93 93, 265, 296 |
4 |
Obinutuzumab
| 2件: Gazyvaro Gazyvaro; OBINUTUZUMAB | 1件: D09321
D09321
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 49 49, 222 |
5 |
Ocrelizumab
| 2件: Ocrelizumab Ocrelizumab; OCREVUS | 1件: D05218
D05218
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 46, 49 |
6 |
Octreotide
| 3件: Octreotide Octreotide; OCTREOTIDE ACETATE; Sandostatin LAR | 2件: D00442
D00442
,
D06495
| 1件: SSTR2 SSTR2 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 7件: 67 67, 75, 84, 85, 89, 193, 227 |
7 |
Odevixibat
| 1件: Odevixibat Odevixibat | 1件: D11716
D11716
| 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 3件: 296 296, 297, 338 |
8 |
Odiparcil
| 1件: Odiparcil Odiparcil | - | - | - | 1件: 19 19 |
9 |
Ofatumumab
| 4件: Arzerra Arzerra; HuMax-CD20; Kesimpta; Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 35, 46 |
10 |
Olanzapine
| 2件: OLANZAPINE OLANZAPINE; Zyprexa | 2件: D00454
D00454
,
D06623
| 11件: ADRA1A ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 8 |
11 |
Olaparib
| 1件: Olaparib Olaparib | 1件: D09730
D09730
| 2件: PARP1 PARP1, PARP2 💬 | 5件: Apoptosis Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis 💬 | 2件: 86 86, 285 |
12 |
Olea europaea leaf
| 1件: Olive Olive | - | - | - | 3件: 13 13, 49, 53 |
13 |
Oleic Acid
| 1件: Oleic Acid Oleic Acid | 1件: D02315
D02315
| - | - | 2件: 13 13, 299 |
14 |
Olenasufligene relduparvovec
| 1件: OLENASUFLIGENE RELDUPARVOVEC OLENASUFLIGENE RELDUPARVOVEC | - | - | - | 1件: 19 19 |
15 |
Olipudase alfa
| 1件: Olipudase alfa Olipudase alfa | 1件: D10820
D10820
| 1件: SMPD1 SMPD1 💬 | 5件: Lysosome Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway 💬 | 1件: 19 19 |
16 |
Olive oil
| 1件: Olive Oil Olive Oil | 1件: D03311
D03311
| - | - | 3件: 13 13, 49, 53 |
17 |
Olokizumab
| 1件: Olokizumab Olokizumab | - | - | - | 2件: 46 46, 96 |
18 |
Olsalazine
| 1件: Olsalazine Olsalazine | 2件: D00727
D00727
,
D08295
| - | - | 1件: 271 271 |
19 |
OM85
| 1件: Broncho-Vaxom Broncho-Vaxom | - | - | - | 1件: 85 85 |
20 |
Omadacycline
| 1件: Omadacycline Omadacycline | 1件: D09647
D09647
| - | - | 1件: 299 299 |
21 |
Omalizumab
| 2件: Omalizumab Omalizumab; Xolair | 1件: D05251
D05251
| 1件: FCER1A FCER1A 💬 | 4件: Asthma Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬 | 7件: 46 46, 53, 65, 98, 162, 226, 299 |
22 |
Omaveloxolone
| 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
23 |
Omega-3 fatty acids
| 6件: Omega 3 fatty acids Omega 3 fatty acids; Omega-3; Omega-3 fatty acid; Omega-3 fatty acids; OMEGA-3-ACID TRIGLYCERIDES; Phospholipids | - | - | - | 8件: 13 13, 46, 49, 53, 66, 79, 96, 299 |
24 |
Omega-3-carboxylic acids
| 1件: Epanova Epanova | - | - | - | 1件: 96 96 |
25 |
Omeprazole
| 5件: Losec Losec; Omeprazol; Omeprazole; Omeprazole 20 mg; OMEPRAZOLE MAGNESIUM | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 16件: 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
26 |
Omigapil
| 1件: Omigapil Omigapil | - | - | - | 1件: 113 113 |
27 |
Onasemnogene abeparvovec
| 3件: ONASEMNOGENE ABEPARVOVEC ONASEMNOGENE ABEPARVOVEC; Onasemnogene Abeparvovec-xioi; Zolgensma | 1件: D11559
D11559
| 1件: SMN1 SMN1 💬 | - | 1件: 3 3 |
28 |
Ondansetron
| 1件: Ondansetron Ondansetron | 2件: D00456
D00456
,
D00678
| 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 4件: 6 6, 97, 107, 231 |
29 |
Ontamalimab
| 1件: Ontamalimab Ontamalimab | - | - | - | 2件: 96 96, 97 |
30 |
Opicapone
| 2件: Ongentys Ongentys; OPICAPONE | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
31 |
Opicinumab
| 1件: Opicinumab Opicinumab | 1件: D11767
D11767
| 1件: LINGO1 LINGO1 💬 | - | 1件: 13 13 |
32 |
Oprelvekin
| 5件: IL-11 IL-11; Interleukin 11; Interleukin-11; Oprelvekin; Recombinant interleukin-11 | 1件: D05266
D05266
| 1件: IL11RA IL11RA 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 2件: 96 96, 288 |
33 |
ORE-1001
| 0件: | - | - | - | 1件: 97 97 |
34 |
Orelabrutinib
| 1件: Orelabrutinib Orelabrutinib | 1件: D12160
D12160
| 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 3件: 13 13, 61, 63 |
35 |
Orilanolimab
| 1件: ORILANOLIMAB ORILANOLIMAB | 1件: D12144
D12144
| 1件: FCGRT FCGRT 💬 | - | 1件: 61 61 |
36 |
ORM-12741
| 1件: ORM-12741 ORM-12741 | - | - | - | 1件: 51 51 |
37 |
Ornithine
| 1件: Ornithine Ornithine | 1件: D08302
D08302
| - | - | 2件: 245 245, 251 |
38 |
Oseltamivir
| 1件: Oseltamivir Oseltamivir | 2件: D00900
D00900
,
D08306
| - | - | 2件: 97 97, 299 |
39 |
Osilodrostat
| 1件: OSILODROSTAT OSILODROSTAT | 1件: D11061
D11061
| 1件: CYP11B2 CYP11B2 💬 | 3件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
40 |
Otelixizumab
| 1件: Otelixizumab Otelixizumab | 1件: D08959
D08959
| 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 46 46 |
41 |
Otilimab
| 1件: Otilimab Otilimab | 1件: D11343
D11343
| 1件: CSF2 CSF2 💬 | 16件: Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 46 46, 256 |
42 |
Oxandrolone
| 1件: Oxandrolone Oxandrolone | 1件: D00462
D00462
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 2件: 211 211, 285 |
43 |
Oxatomide
| 1件: Oxatomide Oxatomide | 1件: D01773
D01773
| 1件: ALOX5 ALOX5 💬 | 6件: Arachidonic acid metabolism Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬 | 1件: 113 113 |
44 |
Oxcarbazepine
| 2件: Oxcarbazepine Oxcarbazepine; Trileptal | 1件: D00533
D00533
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 |
45 |
Oxiconazole
| 1件: Oxiconazole Oxiconazole | 2件: D00885
D00885
,
D08313
| - | - | 1件: 160 160 |
46 |
Oxybuprocaine
| 1件: Oxybuprocaine Oxybuprocaine | 2件: D01768
D01768
,
D08319
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
47 |
Oxybutynin
| 1件: Oxybutynin Oxybutynin | 2件: D00465
D00465
,
D00722
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 13, 53 |
48 |
Oxycodone
| 3件: Oxycodone Oxycodone; OXYCODONE HYDROCHLORIDE; Oxycodone/Acetaminophen | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 13, 46, 70, 226, 231, 298 |
49 |
Oxygen
| 3件: Medical air Medical air; Nitrogen; Oxygen | 1件: D00003
D00003
| - | - | 20件: 6 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330 |
50 |
Oxymatrine
| 1件: Oxymatrine Oxymatrine | - | - | - | 1件: 37 37 |
51 |
Oxymorphone
| 1件: Opana Opana | 1件: D08323
D08323
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
52 |
Oxyquinoline
| 1件: Oxine Oxine | 1件: D05321
D05321
| - | - | 1件: 13 13 |
53 |
Oxytocin
| 2件: OXYTOCIN OXYTOCIN; Syntocinon | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 6件: 6 6, 72, 127, 193, 206, 226 |
54 |
Oyster
| 1件: Oyster Oyster | - | - | - | 1件: 84 84 |
55 |
Ozanezumab
| 1件: Ozanezumab Ozanezumab | 1件: D10331
D10331
| 1件: RTN4 RTN4 💬 | 1件: Alzheimer disease Alzheimer disease 💬 | 1件: 2 2 |
56 |
Ozanimod
| 2件: Ozanimod Ozanimod; Zeposia | 1件: D10968
D10968
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 |
57 |
Ozone
| 1件: Ozone Ozone | - | - | - | 3件: 49 49, 51, 226 |
58 |
Ozoralizumab
| 1件: Ozoralizumab Ozoralizumab | 1件: D09944
D09944
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |